Výsledky vyhledávání - "Aurelie Danel"

Medical Nutrition Terminology and Regulations in the United States and Europe—A Scoping Review: Report of the ISPOR Nutrition Economics Special Interest Group

Autor: Sheri Volger, Mickaël Hiligsmann, Clarissa Cooblall, Karen Freijer, Irene Lenoir-Wijnkoop, Silvia M. A. A. Evers, Elizabeth Molsen-David, Aurelie Danel, János G Pitter

Publikováno v: Value in Health. 22:1-12

Background The term medical nutrition (MN) refers to nutritional products used under medical supervision to manage disease- or condition-related dietary needs. Standardized MN definitions, aligned with regulatory definitions, are needed to facilitate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765eac57e4d794475d0d3725ceac3623
https://doi.org/10.1016/j.jval.2018.07.879

Zobrazit plný text záznamu

Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost–consequence model

Autor: Aurelie Danel, Douglas L. Nguyen, Alistair S Curry, Shkun Chadda

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Alistair S Curry,1 Shkun Chadda,1 Aurélie Danel,2 Douglas L Nguyen3 1Health Economics, SIRIUS Market Access, London UK; 2Market Access, Nestlé Health Science, Vevey, Switzerland; 3University of California-Irvine Department of Medicine, Orange, CA,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b665d8e36da7ddebf9c9032ef043a88
http://europepmc.org/articles/PMC5993029

Zobrazit plný text záznamu

Akademický článek

Clinical and economic burden of surgical complications during hospitalization for digestive cancer surgery in France

Autor: Guillaume Piessen, Catherine Dive‐Pouletty, Aurélie Danel, Magali Laborey, Benoît Thomé

Publikováno v: Cancer Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)

Abstract Background Surgical complications and particularly infections after digestive cancer surgery remain a major health and economic problem and its burden in France is not well documented. Aims The aim of this study was to analyse recent data re

Externí odkaz: https://doaj.org/article/c3ec3a1383d74bc68ff4c37e8a1472c8

Zobrazit plný text záznamu

A systematic scoping review on the consequences of stress-related hyperglycaemia

Autor: N Pooley, Elena Olariu, Jean-Charles Preiser, Montserrat Miret, Aurelie Danel

Publikováno v: PLoS ONE
PLoS ONE, Vol 13, Iss 4, p e0194952 (2018)
PloS one, 13 (4

Background Stress-related hyperglycaemia (SHG) is commonly seen in acutely ill patients and has been associated with poor outcomes in many studies performed in different acute care settings. We aimed to review the available evidence describing the as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80173a727d01574316304ec525d3419c
https://pubmed.ncbi.nlm.nih.gov/29624594

Zobrazit plný text záznamu

Effects of arginine-based immunonutrition on inpatient total costs and hospitalization outcomes for patients undergoing colorectal surgery

Autor: Louis P. Garrison, Souvik Banerjee, Aurelie Danel, Juan B. Ochoa Gautier, David R. Flum

Publikováno v: Nutrition (Burbank, Los Angeles County, Calif.). 42

Objective The aim of this study was to assess the effects of an arginine-based immunonutrition intervention for patients undergoing elective colorectal surgery on postsurgical utilization and cost outcomes. Methods This analysis was based on data fro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163772b5d8b6470e8eabe8779a7ecc46
https://pubmed.ncbi.nlm.nih.gov/28734748

Zobrazit plný text záznamu

Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model

Autor: Denis Getsios, Ipek Özer Stillman, Phillip McEwan, Aurelie Danel, J. Jaime Caro

Publikováno v: Journal of Medical Economics. 10:239-254

SummaryRimonabant, the first selective CB-1 receptor blocker, is expected to reduce cardiometabolic risk substantially. This study assesses the economics of such treatment in patients at elevated cardiometabolic risk.A Markov model was developed usin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a422b3b2604643224102a062edc20896
https://doi.org/10.3111/13696990701438629

Zobrazit plný text záznamu

Economic costs of chemotherapy-induced febrile neutropenia among patients with non-Hodgkin's lymphoma in European and Australian clinical practice

Autor: A. Marciniak, Ruth Pettengell, Aurelie Danel, Derek Weycker, Kate Bendall, Michael Lipsitz

Publikováno v: BMC Cancer
BMC Cancer, Vol 12, Iss 1, p 362 (2012)

Background Economic implications of chemotherapy-induced febrile neutropenia (FN) in European and Australian clinical practice are largely unknown. Methods Data were obtained from a European (97%) and Australian (3%) observational study of patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4e81c3c9fe7b01e74e2d3311489337
https://openaccess.sgul.ac.uk/id/eprint/103227/1/1471-2407-12-362.pdf

Zobrazit plný text záznamu

Cost of Chemotherapy-Induced Febrile Neutropenia Treated in Inpatient, Outpatient, and Home Settings Among Adults with Non-Hodgkin's Lymphoma in European Clinical Practice

Autor: Kate Bendall, Ruth Pettengell, Michael Lipsitz, Derek Weycker, Aurelie Danel

Publikováno v: Blood. 118:4200-4200

Abstract 4200 Background: Neutropenia is a frequent complication of myelosuppressive chemotherapy. In the presence of fever or other evidence of infection, neutropenia typically necessitates inpatient care, although a minority of less severe episodes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23a4d0caccd76d0c8bf5f08d72fd422b
https://doi.org/10.1182/blood.v118.21.4200.4200

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání